Journalartikel

Acetylcholine and molecular components of its synthesis and release machinery in the urothelium


AutorenlisteLips, Katrin S.; Wunsch, Julia; Zarghooni, Shirin; Bschleipfer, Thomas; Schukowski, Konstantin; Weidner, Wolfgang; Wessler, Ignaz; Schwantes, Ulrich; Koepsell, Hermann; Kummer, Wolfgang

Jahr der Veröffentlichung2007

Seiten1042-1053

ZeitschriftEuropean Urology

Bandnummer51

Heftnummer4

ISSN0302-2838

DOI Linkhttps://doi.org/10.1016/j.eururo.2006.10.028

VerlagElsevier


Abstract

Objectives: Previous studies provided indirect evidence for urothelial synthesis and release of acetylcholine (ACh). We aimed to determine directly the ACh content in the urothelium and to characterize the molecular components of its synthesis and release machinery.

Methods: The study was performed on mouse bladder and abraded urothelium, and human mucosal bladder biopsies. ACh content was measured by high-performance liquid chromatography-electrochemical. Reverse transcriptase-polymerase chain reaction (RT-PCR) and immunohistochemistry served to investigate expression of ACh-synthesizing enzymes-choline acetyltransferase (ChAT) and carnitine acetyltransferase (CarAT)-vesicular ACh transporter (VAChT), and polyspecific organic cation transporters (OCTs; isoforms 1-3). Transfected cells served to investigate whether the anticholinergic drug trospium chloride interferes with ACh-transporting OCTs.

Results: ACh is present in the urothelium. in a nanomolar range per gram of wet weight. RT-PCR data support the presence of CarAT but not ChAT. VAChT, used by neurons to shuffle ACh into synaptic vesicles, is detected in subepithelial cholinergic nerve fibres, but not by RT-PCR or immunohistochemistry in the urothelium. OCT1 and OCT3 are expressed by the urothelium. The quarternary ammonium base trospium chloride inhibits cation transport by OCTs with a potency rank order of OCT2 (IC50 = 0.67 +/- 0.42 mu mol/l) > OCT1 (IC50 = 6.2 +/- 2.1 mu mol/l) > OCT3 (IC50 = 871 +/- 177 mu mol/l).

Conclusions: This study demonstrates a urothelial non-neuronal cholinergic system that differs widely from that of neurons with respect to molecular components of the ACh synthesis and release machinery. Consequently, these two systems might be differentially targeted by pharmacologic approaches. (c) 2006 European Association of Urology. Published by Elsevier B.V. All rights reserved.




Zitierstile

Harvard-ZitierstilLips, K., Wunsch, J., Zarghooni, S., Bschleipfer, T., Schukowski, K., Weidner, W., et al. (2007) Acetylcholine and molecular components of its synthesis and release machinery in the urothelium, European Urology, 51(4), pp. 1042-1053. https://doi.org/10.1016/j.eururo.2006.10.028

APA-ZitierstilLips, K., Wunsch, J., Zarghooni, S., Bschleipfer, T., Schukowski, K., Weidner, W., Wessler, I., Schwantes, U., Koepsell, H., & Kummer, W. (2007). Acetylcholine and molecular components of its synthesis and release machinery in the urothelium. European Urology. 51(4), 1042-1053. https://doi.org/10.1016/j.eururo.2006.10.028



Schlagwörter


acetyltransferaseaceytlcholineBIOLOGICAL-SYSTEMSBLADDERcarnitine acetyltransferasecholine acetyltransferaseCHOLINERGIC GENE LOCUSNONNEURONAL ACETYLCHOLINEPOLYSPECIFIC CATION TRANSPORTERS


Nachhaltigkeitsbezüge


Zuletzt aktualisiert 2025-18-06 um 13:48